Catherine E. Willoughby

Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Roser Pinyol, Sara Torrecilla, Huan Wang et al. · Journal of Hepatology · 2021 · 230 citations · Full text

Medicine, Molecular Biology, Pathology +15

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 228 citations · Full text

Medicine, Immunology, Oncology +17

Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma

Laura Torrens, Carla Montironi, Marc Puigvehí et al. · Hepatology · 2021 · 163 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Imagestream detection and characterisation of circulating tumour cells – A liquid biopsy for hepatocellular carcinoma?

Laura Ogle, James Orr, Catherine E. Willoughby et al. · Journal of Hepatology · 2016 · 139 citations

Medicine, Cancer Biology, Oncology +17

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Jane Margetts, Laura Ogle, Stephen L. Chan et al. · British Journal of Cancer · 2017 · 120 citations · Full text

Medicine, Immunology, Oncology +17